Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization

Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization

US Patent 9617272 · Granted Apr 11, 2017

Estimated economic value: $8,022,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted amide compounds useful as farnesoid X receptor modulators2025
Piperazine substituted indazole compounds as inhibitors of PARG2025
Substituted bicyclic compounds as farnesoid X receptor modulators2025
Substituted amide compounds useful as farnesoid X receptor modulators2024
TDO2 and IDO1 inhibitors2023
TDO2 and IDO1 inhibitors2023
Substituted bicyclic compounds as farnesoid X receptor modulators2023
Salts and prodrugs of 1-methyl-d-tryptophan2022
Salts and prodrugs of 1-methyl-d-tryptophan2022
Salts and prodrugs of 1-methyl-d-tryptophan2022
Salts and prodrugs of 1-methyl-d-tryptophan2022
Substituted bicyclic compounds as farnesoid X receptor modulators2022